Bio-sunscreens (melanin & DNA-repair enzymes)

01Overview and value chain

Markers: [EC: US sunscreens are OTC drugs (FDA monograph) & EU Cosmetics Regulation 1223/2009 | OECD: Industrial biotechnology | Regulator: FDA (USA), REACH (EU), NMPA (China)]

Bio-sunscreens use biological actives — DNA-repair enzymes, algal mycosporine-like amino acids (MAAs) and biosynthetic melanin — alongside or in place of mineral and chemical UV filters, so the product does not just block photons but actively repairs and absorbs UV damage. Two consumer brands anchor the enzyme line: ISDIN’s Eryfotona Actinica SPF 50+, whose “DNA Repairomes” deliver photolyase that splits UV-induced pyrimidine dimers, and Neova’s DNA Repair line, built on patented photolyase enzymes backed by over 20 years of clinical evidence. The MAA frontier is supplied by B2B marine-biotech houses — Givaudan Active Beauty’s algae-based actives and Mibelle’s mycosporine-like amino acids green-extracted from Nostoc cyanobacteria — while Cantabria Labs’ Heliocare carries the Polypodium leucotomos Fernblock botanical photoprotectant. Three biological UV-defense mechanisms define the segment: photolyase photoreactivation, MAA absorption and botanical polyphenol quenching.

The key directions of bio-sunscreens are:

1. Photolyase DNA-repair enzymes: blue-light-activated enzymes that repair UV-induced DNA damage — ISDIN DNA Repairomes, Neova.
2. Mycosporine-like amino acids (MAAs): algal/cyanobacterial UV- absorbing compounds (e.g. from Nostoc) supplied as B2B actives — Givaudan Active Beauty, Mibelle.
3. Biosynthetic / fermented melanin: microbiologically produced melanin as a broadband biological UV absorber (research frontier).
4. Botanical photoprotectants: plant-extract actives with documented photoprotection — Cantabria Labs’ Polypodium leucotomos Fernblock.

Sectoral value chain

[bio-active sourcing] ──> [extraction / fermentation] ──> [formulation] ──> [SPF + stability testing]
                                       │
                              (enzyme / MAA / extract)
                                       │
                                       ▼
[retail (pharmacy/derm)] <─── [regulatory (OTC drug / cosmetic)] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Photolyase photoreactivation (Photolyase Photoreactivation): a blue-light-activated enzyme that monomerizes cyclobutane pyrimidine dimers caused by UVB.
• MAA UV absorption (MAA UV Absorption): mycosporine-like amino acids from algae/cyanobacteria absorb in the UVA range and are formulated as B2B cosmetic actives.
• Botanical polyphenol photoprotection (Botanical Polyphenol Photoprotection): fern and plant polyphenols (Polypodium leucotomos) quench UV-induced reactive oxygen species.

02US

The US holds the photolyase DNA-repair consumer brand, operating under the FDA’s OTC-drug sunscreen monograph.

photolyase DNA-repair enzymes

• Neova: a patented photolyase DNA-repair enzyme platform — DNA Repair Enzyme Serum and DNA Damage Control — that targets UV damage at the DNA level, backed by over 20 years of clinical evidence.
• FDA OTC-drug framing: US sunscreens are regulated as OTC drugs under the FDA monograph, so any bio-active sunscreen carries drug-level efficacy and safety obligations.

03CN

China’s sunscreen market is dominated by mineral (zinc oxide) and chemical UV filters, with no originator of photolyase, MAA or biosynthetic-melanin actives, so the regional picture is qualitative rather than vendor-led.

mineral/chemical SPF dominance, no bio-active originator

• NMPA special-cosmetics registration: sunscreens are special cosmetics requiring NMPA registration, with no distinct pathway for enzyme/MAA bio-actives.
• No domestic bio-active originator: the photolyase/MAA/melanin active layer is imported, not originated in China; domestic output is mineral and chemical SPF.
• Botanical-extract adjacency: Chinese brands add botanical extracts to SPF formulations, but none has commercialized a genuine enzyme or MAA active.

04EU

Europe anchors the segment, supplying both the consumer photolyase brand and the B2B MAA marine-biotech layer, under the Cosmetics Regulation.

photolyase sunscreen, MAA B2B actives, botanical photoprotection

• ISDIN (Spain): Eryfotona Actinica SPF 50+ mineral sunscreen with DNA Repairomes (photolyase) — a top dermatologist-recommended bio-active sunscreen line.
• Givaudan Active Beauty (Switzerland): B2B marine-biotech house supplying algae-based UV / preventative anti-ageing actives (porphyrins).
• Mibelle (Switzerland): B2B bio-active supplier of mycosporine-like amino acids (MAAs) green-extracted from Nostoc cyanobacteria.
• Cantabria Labs (Spain): Heliocare 360 and ASPA-Fernblock, the Polypodium leucotomos fern-extract botanical photoprotectant (oral and topical).
• EU Cosmetics Regulation framing: sunscreens are cosmetics under EC 1223/2009, a lighter regime than the US OTC-drug track.

05Leading companies and research institutes

06Tech stack and innovations

The stack rests on three biological platforms: blue-light-activated DNA-repair enzymes, algal/cyanobacterial UV-absorbing amino acids, and botanical polyphenol photoprotection.

1. Photolyase DNA-repair enzymes (Photolyase DNA-Repair Enzymes):
   • photolyase monomerizes UV-induced cyclobutane pyrimidine dimers using blue-light energy (photoreactivation), repairing DNA damage that filters cannot prevent.
   • case: ISDIN’s DNA Repairomes (Eryfotona) and Neova’s patented photolyase platform, with 20+ years of clinical evidence.
2. Mycosporine-like amino acids / MAAs (Mycosporine-Like Amino Acids):
   • algal and cyanobacterial MAAs (e.g. from Nostoc) absorb in the UVA range and are supplied as B2B cosmetic actives.
   • case: Mibelle’s green-extracted Nostoc MAAs and Givaudan Active Beauty’s algae-based marine-biotech actives.
3. Botanical polyphenol photoprotection (Botanical Polyphenol Photoprotection):
   • fern (Polypodium leucotomos) polyphenols quench UV-induced reactive oxygen species and support skin’s photoprotection.
   • case: Cantabria Labs’ Fernblock in the Heliocare 360 line, oral and topical.

07Value chains and production pipelines

Industrial pipeline of a photolyase bio-active sunscreen (FDA OTC-drug / EU cosmetic)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Bio-active sourcing    │ ───> │ 2. Extraction/fermentation │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. SPF & stability testing│ <─── │ 3. Formulation            │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Regulatory filing      │ ───> │ 6. Retail (pharmacy/derm) │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Bio-active sourcing

Photolyase feedstock (plankton), MAA-producing cyanobacteria (Nostoc), or fern biomass (Polypodium leucotomos) are sourced or cultured as the bio-active origin.

Stage 2: Extraction / fermentation

The enzyme is isolated (or melanin fermented in a bioreactor), MAAs are green-extracted from cyanobacterial biomass, or the fern extract is standardized to its polyphenol content.

Stage 3: Formulation

The purified bio-active is blended with mineral or chemical UV filters and excipients into a sunscreen base or a leave-on serum.

Stage 4: SPF & stability testing

The finished formula is tested for SPF value, photostability, and — for enzyme actives — residual enzyme activity across shelf life.

Stage 5: Regulatory filing

In the US the product is filed under the FDA OTC-drug sunscreen monograph; in the EU under the Cosmetics Regulation (EC 1223/2009); in China as a special cosmetic with NMPA.

Stage 6: Retail

The validated product reaches consumers through pharmacy, dermatologist and DTC channels — ISDIN Eryfotona and Heliocare through pharmacy/derm, Neova through retail and DTC.